Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis

Slides:



Advertisements
Similar presentations
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Advertisements

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Antifungal Drugs: Actions and Uses
Introduction to Antimicrobial Drugs. –Antibacterial –Antiviral –Antifungal –Antiprotozoan –Anthelmintic Classification by Susceptible Organism.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Antiinfective Agents.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
PENICILLIN G PRESENT BY: ADEL T. AL-OHALI. Introduction: Penicillin G is one of the natural penicillins. it discover at 1929 and did not use until 1941.
Antibiotics Ch 37. Definition Medications to treat bacterial infections Ideally, culture of suspect area should be done BEFORE starting antibiotic.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere.
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 85 Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines,
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 41 Antifungal Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Antifungal Agents.
Malaria Chemoprophylaxis
 The ARBs include the following drugs:  azilsartan (Edarbi),candesartan (Atacand), eprosartan (Teveten), irbesartan(Avapro), losartan (Cozaar), olmesartan.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, Clindamycin, Linezolid,
Antibiotics Affecting Protein Synthesis Medications for Infection.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. Some material was previously published. 1 Unit 3 Seminar Dr. Amy Thompson.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Dr. Steven I. Dworkin Cephalosporins Treatment of a wide range of bacteria including those sensitive to penicillin. 4 Groupings –First Generation to Fourth.
Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others.
Focus on Pharmacology Essentials for Health Professionals
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA
Miscellaneous Antibiotics
4. Antibiotics - Polymyxins (Polypeptides)
Aminoglycosides.
Drugs used in Meningitis Prof. Azza ELMedany
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 15 Opioid Analgesics
Posterior pituitary hormones: Vasopressin
Other Protein Synthesis Inhibitor
Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs
Introduction to Sulfonamides
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Broad-spectrum antibiotics
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 33 Diuretics
Other Protein Synthesis Inhibitor
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
2- Tetracyclines Classification
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Antibacterial Drugs: Sulfonamides
Cholinesterase Inhibitors: Actions and Uses
Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates
Introduction to Sedatives and Hypnotics #1
Cholinergic Blocking Drugs: Actions
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis

Tetracyclines Anti-infectives composed of natural and semisynthetic compounds Actions: inhibit bacterial protein synthesis Used as broad-spectrum antibiotic when penicillin is contraindicated Treat the following infections: Rickettsial diseases such as Rocky Mountain spotted fever; typhus fever, tick fevers; intestinal amebiasis; skin and soft tissue infections; uncomplicated urethral, endocervical, or rectal infections; adjunctive treatment; and infection with Helicobacter pylori

Tetracyclines: Adverse Reactions Gastrointestinal/other body system reactions: Nausea and/or vomiting Diarrhea Epigastric distress Stomatitis Sore throat Skin rashes Photosensitivity reaction

Tetracyclines: Contraindications Contraindicated in patients: With hypersensitivity; during pregnancy, lactation; children younger than 9 years because may cause discoloration of teeth turning them yellow-gray- brown color Nursing alert: Not given to children younger than 9 years of age Prolonged therapy: Bacterial/fungal overgrowth of nonsusceptible organisms

Tetracyclines: Precautions Used cautiously in patients with: Impaired renal function Liver impairment Chronic care alert: May reduce insulin requirements in patients with diabetes. Blood glucose levels should be monitored frequently.

Tetracyclines: Interactions #1 Interacting drug Effect of interaction Antacids containing aluminum, zinc, magnesium, or bismuth salts Decreases effectiveness of tetracyclines Oral anticoagulants like warfarin Increases risk for bleeding Oral contraceptives Decreases effectiveness of contraceptive agent

Tetracyclines: Interactions #2 Interacting drug Effect of interaction Digoxin Increases the risk for digitalis toxicity Calcium-rich foods Causes potentially impaired absorption of tetracycline

Aminoglycosides: Actions and Uses Blocks step in protein synthesis necessary for bacterial multiplication-amikacin, gentamicin, kanamycin, neomycin, streptomycin, and tobramycin Used against gram-negative microorganisms Bowel preparation-kanamycin is used preoperatively to keep bowel as clean as possible for surgery Hepatic coma-ensure patient does not have problems with swallowing and level of consciousness

Aminoglycosides: Adverse Reactions Nausea Vomiting Anorexia Rash Urticaria Nephrotoxicity (damage to the kidneys by a toxic substance); assess kidneys for hematuria; decreased urine output; monitor lab values for proteinuria and increased creatinine Ototoxicity (damage to the hearing organs by a toxic substance) Neurotoxicity (damage to the nervous system by a toxic substance) will have paresthesias, tingling around mouth, and muscle twitching

Aminoglycosides: Contraindications and Precautions Contraindicated in patients: With hypersensitivity to aminoglycosides, pre- existing hearing loss, myasthenia gravis, parkinsonism; during lactation and pregnancy (category C and D). Long-term therapy risk: ototoxicity and nephrotoxicity. Used cautiously in: Elderly patients; patients with renal failure and neuromuscular disorders

Aminoglycosides: Interactions Cephalosporins Loop diuretics Pavulon or Anectine

Macrolides Broad spectrum antibiotics; used in people allergic to penicillin Effective against a wide variety of pathogenic organisms, particularly infections of the respiratory and genitourinary tracts Actions: Act by causing changes in protein function and synthesis

Macrolides: Uses Used as prophylaxis before dental or other procedures in patients allergic to penicillin and in the treatment of: A wide range of gram-negative and gram-positive infections Acne vulgaris and skin infections Upper respiratory infections caused by Haemophilus influenza

Adverse Reactions of Macrolides Gastrointestinal (GI) and other reactions: Nausea Vomiting Diarrhea Abdominal pain or cramping Pseudomembranous colitis Visual disturbances

Macrolides: Contraindications and Precautions Contraindicated in patients: With a hypersensitivity to the macrolides; with pre- existing liver disease; prescribed cisapride (Propulsid) or pimozide (Orap) Used cautiously in patients: With liver dysfunction; with myasthenia gravis; during pregnancy or lactation (pregnancy category B and C)

Macrolides: Interactions #1 Interacting Drug Effect of Interaction Antacids (kaolin, aluminum salts, or magaldrate) Decreases absorption and effectiveness of macrolide Digoxin Increases serum levels of digoxin Anticoagulants Increases risk of bleeding

Macrolides: Interactions #2 Interacting Drug Effect of Interaction Clindamycin, lincomycin, or chloramphenicol Decreases therapeutic activity of the macrolide Theophylline Increases serum theophylline level

Lincosamides Used for treating serious infections in which penicillin or erythromycin is not effective Used for the more serious infections Used in conjunction with other antibiotics Actions: Inhibits protein synthesis in susceptible bacteria, causing cell death Effective in the treatment of infections caused by a wide range of gram-negative and gram-positive microorganisms

Lincosamides: Adverse Reactions Gastrointestinal/other body reactions: Abdominal pain Esophagitis Nausea Vomiting Diarrhea Skin rash Blood dyscrasias

Lincosamides: Contraindications and Precautions Contraindicated in patients: With hypersensitivity to the lincosamides; prescribed cisapride (Propulsid) or the antipsychotic drug pimozide (Orap); having minor bacterial or viral infections Used cautiously in patients with: History of GI disorders; renal disease; hepatic impairment; myasthenia gravis

Lincosamides: Interactions Interacting Drug Effect of Interaction Kaolin or aluminum-based antacids Decreases absorption of the lincosamide Neuromuscular blocking drugs Increases action of neuromuscular blocking drug, possibly leading to severe and profound respiratory depression

Nursing Process: Assessment #1 Preadministration assessment: Establish an accurate database before the administration of any antibiotic Obtain general health history Record vital signs and obtain description of signs and symptoms Note patient’s general appearance Obtain culture and sensitivity test results

Nursing Process: Assessment #2 Ongoing assessment: Take vital signs every 4 hours or as ordered; Notify the primary health care provider if there are changes in the vital signs, such as a significant drop in blood pressure, an increase in the pulse or respiratory rate, or a sudden increase in temperature.  Compare current signs and symptoms of infection and record any specific findings

Nursing Process: Nursing Diagnoses #1 Impaired Comfort: increased Fever related to ineffectiveness of anti-infective therapy Acute Confusion related to increased ammonia blood levels Ineffective Tissue Perfusion: renal related to adverse drug reactions to aminoglycosides

Nursing Process: Nursing Diagnoses #2 Risk for Injury related to visual disturbances from telithromycin treatment, paresthesia secondary to neurotoxicity, or auditory damage from aminoglycosides Might complain of ringing in the ears and dizziness Diarrhea related to superinfection secondary to anti- infective therapy, adverse drug reaction

Nursing Process: Planning The expected outcome includes an optimal response to therapy: Controlling the infectious process or prophylaxis of bacterial infection Management of adverse drug effects Understanding of and compliance with the prescribed treatment regimen

Nursing Process: Implementation #1 Promoting an optimal response to therapy: Oral administration: tetracyclines On an empty stomach and with a full glass of water (exceptions: minocin and terramycin) Nursing alert: do not give with dairy products, antacids, laxatives, or products containing iron; if prescribed, give 2 hours before/after administration of tetracycline

Nursing Process: Implementation #2 Promoting an optimal response to therapy (cont.) Oral administration: aminoglycosides: enteric- coated erythromycin given with neomycin Drug delivery timing is critical for optimal response of suppression of intestinal bacteria when preparing a patient for surgery with kanamycin or neomycin

Nursing Process: Implementation #3 Promoting an optimal response to therapy (cont.) Oral administration: macrolides Administered without regard to meals and with milk Exceptions: azithromycin, dirithromycin, erythromycin

Nursing Process: Implementation #4 Promoting an optimal response to therapy (cont.) Oral administration: lincosamides Food impairs absorption Patient should not take anything by mouth for 1 to 2 hours before and after Give clindamycin with food or a full glass of water

Nursing Process: Implementation #5 Promoting an optimal response to therapy (cont.) Parenteral administration: Intramuscularly: inspect previous injection sites for signs of pain or tenderness, redness, and swelling, if found report to health care provider; document site Antibiotics: temporary local reactions Rotate injection sites; record site

Nursing Process: Implementation #6 Promoting an optimal response to therapy (cont.) Parenteral administration (cont.) Intravenously: inspect needle site and area around needle for signs of extravasation of the IV fluid or tenderness, pain, and redness When giving quinupristin/dalfopristin IV need to flush line with D5W In case of symptoms: restart the IV in another vein; report to primary health care provider

Nursing Process: Implementation #7 Monitoring and managing patient needs: Observe patient: frequent intervals, especially first 48 hours of therapy Report: any adverse reaction before next dose Serious adverse reactions: severe hypersensitivity reaction, respiratory difficulty, severe diarrhea, severe drop in blood pressure

Nursing Process: Implementation #8 Monitoring and managing patient needs (cont.): Impaired comfort: increased fever Monitor: temperature at frequent intervals Elevated temperature: check temperature, pulse, and respirations every hour until temperature returns to normal; administer antipyretic medication if prescribed

Nursing Process: Implementation #9 Monitoring and managing patient needs (cont.) Risk for injury: Telithromycin: causes difficulty in focusing and accommodating light Caution patients: potential for accidents or injury when driving, operating machinery, or engaging in other hazardous activities

Nursing Process: Implementation #10 Monitoring and managing patient needs (cont.) Diarrhea: superinfection Inspect stools: for blood or mucus Encourage: drinking fluids Maintain: accurate intake, output record Observe: signs or symptoms of bacterial or fungal superinfection

Nursing Process: Implementation #11 Educating the patient and family: Advise to take drug at prescribed time intervals and to not increase or omit dosage unless advised Explain the importance of completing the entire course of treatment Advise taking dose with full glass of water Explain necessity of notifying primary health care provider if symptoms worsen If taking linezolid (Zyvox) avoid foods containing tyramine (e.g., aged cheese, caffeinated beverages, yogurt, chocolate, red wine, beer, pepperoni)—risk of severe hypertension

Nursing Process: Implementation #12 Educating the patient and family (cont.): Advise to avoid alcoholic beverages during therapy If tetracycline is prescribed: advise to avoid exposure to the sun or tanning lamps or beds; completely cover arms and legs and wear wide-brimmed hat to protect face and neck; sunscreen: may or may not be effective; consult primary health care provider; if taking an iron therapy for anemia need to advise to take medication at least 2 hours apart from each other; need to avoid yogurt, cheese, and calcium fortified cereals If tetracycline is prescribed for acne take on empty stomach

Nursing Process: Evaluation The therapeutic effect is achieved; infection is controlled; normal vision unaffected; no diarrhea Adverse reactions: identified, reported, and managed Patient and family demonstrate understanding of drug regimen Patient verbalizes the importance of complying with prescribed therapeutic regimen